Recruiting NA INTERVENTIONAL 4-arm NCT05578716

Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula (GRANDIOSA)

GRANDIOSA - Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula

Sponsor: Arla Foods

Interventions Partially hydrolysed formula

Updated 5 times since 2022 Last updated: Dec 11, 2023 Started: Oct 3, 2022 Primary completion: Jun 30, 2026 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Infant Formula and is currently actively recruiting participants. Arla Foods leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Sep 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA
Nov 2022 — Jan 2024 [monthly]

Recruiting NA

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Arla Foods
Lund University
Umeå University

Data source: Umeå University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Malmo, Sweden
• Umeå, Sweden